In addition and knowing that processes other than mitosis require Eg5, such as growth and morphology of postmitotic neurons (49–51), defective action of Eg5 might contribute to neurological abnormalities of patients with XP-D. The gene discussed is KIF11; the disease is xeroderma pigmentosum group D.